![Geoffrey Nichol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey Nichol
Corporate Officer/Principal chez
ABCELLERA BIOLOGICS INC.
Fortune : 1 019 $ au 31/05/2026
Profil
Actuellement, Geoffrey M. Nichol occupe le poste de Chief Medical Officer & Senior Vice President chez BioMarin Pharmaceutical, Inc. Le Dr Nichol est également membre du conseil d'administration de Millendo Therapeutics, Inc. Auparavant, le Dr Nichol a occupé les postes de vice-président exécutif chargé de la recherche et du développement chez Sangamo Therapeutics, Inc, de médecin chargé de la recherche clinique chez GlaxoSmithKline Plc, de directeur médical chez Ikaria, Inc, de premier vice-président chargé du développement des produits chez Medarex, Inc et de responsable de la gestion des projets mondiaux chez Novartis Pharmaceuticals Corp. Geoffrey M. Nichol est titulaire d'un MBA de l'université de Warwick et d'un doctorat et d'un diplôme de premier cycle de la Dunedin School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/01/2026 | 666 ( 0 % ) | 1 019 $ | 31/05/2026 |
Postes actifs de Geoffrey Nichol
| Sociétés | Poste | Début |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | 01/05/2023 |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Directeur/Membre du Conseil | - |
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Directeur/Membre du Conseil | 07/07/2022 |
Anciens postes connus de Geoffrey Nichol
| Sociétés | Poste | Fin |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/02/2026 |
| BIOMARIN PHARMACEUTICAL INC. | Directeur Technique/Scientifique/R&D | 04/10/2021 |
| SANGAMO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2016 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Corporate Officer/Principal | 01/01/2009 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/09/2002 |
Formation de Geoffrey Nichol
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Otago Medical School
 Otago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
